Evidence map›Paper›PMID 41026671›Full record

ArticlePLOS digital health2025

Waldo: Automated discovery of adverse events from unstructured self reports.

Karan S Desai, Vijay M Tiyyala, Pranav Tiyyala, Atharva Yeola, Alejandra Gallegos-Rangel, Alejandro Montiel-Torres, Matthew R Allen, Mark Dredze, Ryan G Vandrey, Johannes Thrul and 4 more

Abstract read
In one paragraph

Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Karan S DesaiUniversity of Michigan Medical School, University of Michigan, Ann Arbor, Michigan, United States of America.ORCID https://orcid.org/0000-0002-0515-125X
Vijay M TiyyalaDepartment of Computer Science, Johns Hopkins University, Baltimore, Maryland, United States of America.
Pranav TiyyalaAll India Institute of Medical Sciences, Bhubaneswar, India.
Atharva YeolaDepartment of Electrical & Computer Engineering, University of California San Diego, La Jolla, California, United States of America.
Alejandra Gallegos-RangelThe Qualcomm Institute, University of California San Diego, La Jolla, California, United States of America.
Alejandro Montiel-TorresThe Qualcomm Institute, University of California San Diego, La Jolla, California, United States of America.
Matthew R AllenSchool of Medicine, University of California San Diego, La Jolla, California, United States of America.ORCID https://orcid.org/0009-0003-6372-9405
Mark DredzeDepartment of Computer Science, Johns Hopkins University, Baltimore, Maryland, United States of America.
Ryan G VandreyDepartment of Psychiatry and Behavioral Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Johannes ThrulDepartment of Mental Health, School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.ORCID https://orcid.org/0000-0001-8929-9579
Eric C LeasThe Qualcomm Institute, University of California San Diego, La Jolla, California, United States of America.
Mike HogarthAltman Clinical Translational Research Institute, University of California San Diego, La Jolla, California, United States of America.
Davey M SmithAltman Clinical Translational Research Institute, University of California San Diego, La Jolla, California, United States of America.
John W AyersThe Qualcomm Institute, University of California San Diego, La Jolla, California, United States of America.

Funding

Development of a Longitudinal Observational Research Registry for the Study of Medicinal Cannabis Use and HealthUM1DA059000 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Johannes Thrul, RYAN G VANDREY · 2023 to 2026
$8.1M
Characterizing the Epidemiology of Cannabidiol (CBD) Use Among US adultsK01DA054303 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Eric Leas · 2022 to 2026
$810k
NIDA NIH HHS K01 DA054303NIDA NIH HHS UM1 DA059000
6 · The paper itself

Abstract

Adverse event (AE) detection is labor-intensive and costly given the task is to find rare events. Automated solutions to enhance efficiency, reduce costs, and capture unnoticed safety signals are needed. To develop and evaluate an automated machine learning tool, "Waldo," for AE detection from unstructured social media text data, specifically targeting consumer health products that lack traditional post-market surveillance channels. We tested three models - (i) N-gram model, (ii) BERT (Bidirectional Encoder Representations from Transformers), and (iii) RoBERTa (Robustly optimized BERT approach) - trained on 10,000 previously published unstructured reports on cannabis-derived products (CDPs) annotated by humans for the presence of adverse events to determine the best-performing AE detection method. This method was then benchmarked against an AI chatbot (ChatGPT: gpt-3.5-turbo-0613) and applied to previously unstudied user narratives about CDPs from 20 subreddits.RoBERTa demonstrated the highest accuracy at 99.7%, hereafter referred to as Waldo, with 22 false positives and 12 false negatives, yielding an F1-score of 95.1% for the positive class. In contrast, the chatbot had an accuracy of 94.4%, with 401 false positives (18.23-fold more than Waldo) and 163 false negatives (13.58-fold more than Waldo), yielding an F1-score of 38% for the positive class. Applying Waldo to 437,132 posts identified 28,832 potential AEs. The subreddit r/Marijuana had the highest AE rate (12.7%), followed by r/weed (10.5%) and r/AskTrees (10.0%). r/weedstocks (0.1%), r/macrogrowery (0.2%), and r/weedbiz (0.2%) had the lowest rates of potential AEs. Waldo addresses critical gaps in safety surveillance for unregulated consumer health products by automatically detecting adverse events from social media-a capability absent in traditional industry systems. Unlike existing approaches limited to structured databases or narrow domains, Waldo processes informal user narratives at scale with high precision. We have open-sourced Waldo for immediate application by the health community [https://waldo-ae-detection.github.io/WALDO/].

Identifiers

PMID41026671
PMCPMC12483200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.